MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening

Part of paid clinical trials in Los Angeles, California.

Sponsor
Cedars-Sinai Medical Center
Study ID
NCT05699213
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Lung MRI — DIAGNOSTIC_TEST
    MRI of the lung
  • Blood Draw — DIAGNOSTIC_TEST
    Blood Draw

Study Details

The primary objective of this pilot observational study is to evaluate the accrual and retention rate of a study population from a centralized lung cancer screening program to support MRI and blood-based biomarker research for lung cancer screening.

Key Dates

Start date
Jun 27, 2023
Status verified
Aug 2023
Primary completion
Jun 27, 2026
Completion
Aug 27, 2026

Study Design

Enrollment
30 participants (estimated)

Primary Outcome Measure

Accrual and Retention Rate [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Medical CenterLos AngelesCalifornia90048
Weijia Chua, M.D.

Find similar trials in Los Angeles, CA

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Cedars-Sinai Medical Center· Los Angeles, CA

Related Studies